Unbound MEDLINE

Peptidoglycan induces cyclooxygense-2 expression in macrophages by activating the neutral sphingomyelinase-ceramide pathway. The Journal of biological chemistry [J Biol Chem] Journal article

 
TitlePeptidoglycan induces cyclooxygense-2 expression in macrophages by activating the neutral sphingomyelinase-ceramide pathway.
Author(s)Chen BC, Chang HM, Hsu MJ, Shih CM, Chiu YH, Chiu WT, Lin CH 
InstitutionTaipei Medical University, Taiwan.
SourceJ Biol Chem 2009 Jun 15.
AbstractThe sphingomyelin signal transduction pathway is known to play a role in mediating the action of various cytokines. Herein, we examined the role of neutral sphingomyelinase (nSMase)/ceramide in peptidoglycan (PGN)-induced NF-kappaB activation and cyclooxygenase-2 (COX-2) expression in macrophages. PGN-induced COX-2 expression was attenuated by an nSMase inhibitor (3-O-methyl-sphingomyeline, 3-OMS) and ceramidase, but not by an acidic sphingomyelinase (aSMase) inhibitor (imipramine). C2-ceramide, bacterial SMase (which mimics cellular SMase activity), and a ceramidase inhibitor (N-oleoyl-ethanolamine, NOE) individually had no effect on COX-2 expression; however, they markedly enhanced PGN-induced COX-2 expression. PGN activated nSMase, but not aSMase, resulting in increased ceramide generation. PGN-induced nSMase activation and ceramide formation were inhibited by 3-OMS, but not by imipramine. PGN-induced COX-2 expression was inhibited by a p38 MAPK inhibitor (SB 203580) and dominant negative mutants (DNs) of MKK3, MKK6, and p38 MAPKalpha. 3-OMS selectively inhibited PGN-induced p38 MAPK and MKK3/6 activation, but not JNK or ERK1/2. C2-ceramide, bacterial SMase, and NOE all induced p38 MAPK or MKK3/6 activation. The PGN-mediated increases in kappaB-luciferase activity were also inhibited by 3-OMS and the p38 MAPKalphaDN, but not by imipramine. Furthermore, C2-ceramide caused an increase in kappaB-luciferase activity. Our data demonstrate for the first time that PGN activates the nSMase/ceramide pathway to induce MKK3/6/p38 MAPK activation, which in turn initiates NF-kappaB activation, and ultimately induces COX-2 expression in macrophages. The nSMase/ceramide pathway is required but might not be sufficient for COX-2 expression induced by PGN.
LanguageENG
Pub Type(s)JOURNAL ARTICLE
PubMed ID19531467
  
Advertise on this site.